16 results
Chart of Inhalers for Asthma and COPD
 - SABA - Short Acting Beta-2 Agonists
 - SAMA
Chart of Inhalers ... Combination - LABA ... LABA Combination ... #pulmonary #lung ... #respiratory #pharmacology
Long-Acting Dual Bronchodilators - LAMA/LABA Combo Inhalers 

The FDA approved a new dual bronchodilator (LABA/LAMA) combination
/LABA Combo Inhalers ... is approved for treatment ... according to GOLD 2019 ... #LABA #Combo #Inhalers ... #Combination #Pharmacology
COPD Preferred Treatments - GOLD 2018 

COPD is a common progressive respiratory condition that can be
COPD Preferred Treatments ... - GOLD 2018 ... (long-acting beta2 ... long-acting muscarinic ... GOLD2018 #COPD #Treatment
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... indicate preferred treatment ... LAMA: long-acting ... -agonist; ICS: inhaled ... #Management #Pulmonary
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Chronic Obstructive Pulmonary ... chronic obstructive pulmonary ... corticosteroid; LABA ... #LABA #LAMA #SABA ... #SAMA #ICS #Pharmacology
LABA/ICS Combination Inhalers
Long-Acting Beta2 Agonists (LABA) + Inhaled Corticosteroid (ICS) - Commonly used in Asthma 
Advair
LABA/ICS Combination ... Inhalers Long-Acting ... powder into their lungs ... posts for the COPD treatment ... Naming #Names #Pharmacology
The 2019 Global Initiative for Asthma (GINA) treatment strategy figure for adults and adolescents, annotated to
The 2019 Global ... ICS: inhaled corticosteroids ... receptor antagonists; LABA ... : long-acting β2 ... Management #Stepwise #Pulmonary
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
/LABA/ICS) - ... /LABA) & Eosinophils ... recommendations for the treatment ... won’t have any clinical ... #Indications #Pharmacology
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Inhaled droplet ... characteristic features Clinical ... Tuberculosis Treatment ... Initiating Treatment ... Diagnosis #Management #Treatment
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) and Pulmonary Thromboendarterectomy
Chronic Thromboembolic Pulmonary Hypertension
Definition: mean pulmonary-artery pressure > 25mmHg
Thromboembolic Pulmonary ... Plexiform-lesion formation Clinical ... Ventilation-perfusion lung ... Bypass Other Treatment ... • Promising inhaled